Belgium
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 839.95 M
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
USD 469.93 M
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
3 |
USD 118.52 M
|
Dec. 31, 2023 | USD 17.21 | 1.09% |
|
Belgium |
|
4 |
USD -2.26 M
|
Dec. 31, 2023 | USD 150.68 | -0.48% |
|
Belgium |
|
5 |
USD -14.14 M
|
Dec. 31, 2023 | USD 6.22 | -0.06% |
|
Belgium |
|
6 |
USD -21.50 M
|
Dec. 31, 2023 | USD 2.00 | NA |
|
Belgium |
|
7 |
USD -21.82 M
|
Dec. 31, 2023 | USD 13.71 | -0.44% |
|
Belgium |
|
8 |
USD -32.08 M
|
Dec. 31, 2023 | USD 2.81 | 6.87% |
|
Belgium |
|
9 |
USD -49.42 M
|
Dec. 31, 2023 | USD 9.32 | -0.11% |
|
Belgium |
|
10 |
USD -448.09 M
|
Dec. 31, 2023 | USD 24.20 | -0.41% |
|
Belgium |
The Pharmaceuticals company in Belgium with the highest Operating Cash Flow is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 839.95 M.
The Pharmaceuticals company in Belgium with the lowest Operating Cash Flow is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at USD -448.09 M.
The top 10 Pharmaceuticals companies in Belgium by Operating Cash Flow are UCB SA, Azelis Group NV, Fagron NV, Financière de Tubize SA, Hyloris Pharmaceuticals SA, MDxHealth SA, Ion Beam Applications SA, Sequana Medical NV, Nyxoah S.A. and Galapagos NV.
The bottom 10 Pharmaceuticals companies in Belgium by Operating Cash Flow are Galapagos NV, Nyxoah S.A., Sequana Medical NV, Ion Beam Applications SA, MDxHealth SA, Hyloris Pharmaceuticals SA, Financière de Tubize SA, Fagron NV, Azelis Group NV and UCB SA.